Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report

• Main Authors: Kayo Inoue (Author), Hiroshi Tsubamoto (Author), Tomoko Ueda (Author), Chihiro Tajima (Author), Nami Nakagomi (Author)
• Format: Knjiga
• Izdano: Elsevier, 2020-05-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

A germline pathogenic variant in BRCA2 was secondarily found through genomic sequencing of uterine serous carcinoma. Clinical response to olaparib was observed in recurrent uterine serous carcinoma with a germline BRCA2 mutation. Here, we report, for the first time, a long-term clinical response to...